These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37030079)

  • 1. Urinary volatile organic compounds for colorectal cancer screening: A systematic review and meta-analysis.
    van Liere ELSA; van Dijk LJ; Bosch S; Vermeulen L; Heymans MW; Burchell GL; de Meij TGJ; Ramsoekh D; de Boer NKH
    Eur J Cancer; 2023 Jun; 186():69-82. PubMed ID: 37030079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electronic nose can discriminate colorectal carcinoma and advanced adenomas by fecal volatile biomarker analysis: proof of principle study.
    de Meij TG; Larbi IB; van der Schee MP; Lentferink YE; Paff T; Terhaar Sive Droste JS; Mulder CJ; van Bodegraven AA; de Boer NK
    Int J Cancer; 2014 Mar; 134(5):1132-8. PubMed ID: 23959518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal volatile organic compounds for early detection of colorectal cancer: where are we now?
    Bosch S; Berkhout DJ; Ben Larbi I; de Meij TG; de Boer NK
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):223-234. PubMed ID: 30554400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review with meta-analysis: volatile organic compound analysis to improve faecal immunochemical testing in the detection of colorectal cancer.
    Chandrapalan S; Bosch S; Cubiella J; Guardiola J; Kimani P; Mulder C; Persaud K; de Meij TGJ; Altomare DF; Brenner H; de Boer NKH; Ricciardiello L; Arasaradnam RP
    Aliment Pharmacol Ther; 2021 Jul; 54(1):14-23. PubMed ID: 34004036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk stratification of symptomatic patients suspected of colorectal cancer using faecal and urinary markers.
    Widlak MM; Neal M; Daulton E; Thomas CL; Tomkins C; Singh B; Harmston C; Wicaksono A; Evans C; Smith S; Savage RS; Covington JA; Arasaradnam RP
    Colorectal Dis; 2018 Dec; 20(12):O335-O342. PubMed ID: 30248228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Volatile organic compounds in breath can serve as a non-invasive diagnostic biomarker for the detection of advanced adenomas and colorectal cancer.
    van Keulen KE; Jansen ME; Schrauwen RWM; Kolkman JJ; Siersema PD
    Aliment Pharmacol Ther; 2020 Feb; 51(3):334-346. PubMed ID: 31858615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early detection and follow-up of colorectal neoplasia based on faecal volatile organic compounds.
    Bosch S; Bot R; Wicaksono A; Savelkoul E; van der Hulst R; Kuijvenhoven J; Stokkers P; Daulton E; Covington JA; de Meij TGJ; de Boer NKH
    Colorectal Dis; 2020 Sep; 22(9):1119-1129. PubMed ID: 32040880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exhaled breath and urinary volatile organic compounds (VOCs) for cancer diagnoses, and microbial-related VOC metabolic pathway analysis: a systematic review and meta-analysis.
    Zhou M; Wang Q; Lu X; Zhang P; Yang R; Chen Y; Xia J; Chen D
    Int J Surg; 2024 Mar; 110(3):1755-1769. PubMed ID: 38484261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detecting Colorectal Adenomas and Cancer Using Volatile Organic Compounds in Exhaled Breath: A Proof-of-Principle Study to Improve Screening.
    Cheng HR; van Vorstenbosch RWR; Pachen DM; Meulen LWT; Straathof JWA; Dallinga JW; Jonkers DMAE; Masclee AAM; Schooten FV; Mujagic Z; Smolinska A
    Clin Transl Gastroenterol; 2022 Nov; 13(11):e00518. PubMed ID: 35981245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer and adenoma screening using urinary volatile organic compound (VOC) detection: early results from a single-centre bowel screening population (UK BCSP).
    Mozdiak E; Wicaksono AN; Covington JA; Arasaradnam RP
    Tech Coloproctol; 2019 Apr; 23(4):343-351. PubMed ID: 30989415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Volatile organic compounds analysis as a potential novel screening tool for colorectal cancer: A systematic review and meta-analysis.
    Zhou W; Tao J; Li J; Tao S
    Medicine (Baltimore); 2020 Jul; 99(27):e20937. PubMed ID: 32629696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance of volatile organic compounds analysis and electronic noses for detecting colorectal cancer: a systematic review and meta-analysis.
    Wang Q; Fang Y; Tan S; Li Z; Zheng R; Ren Y; Jiang Y; Huang X
    Front Oncol; 2024; 14():1397259. PubMed ID: 38817891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review: non-endoscopic surveillance for colorectal neoplasia in individuals with Lynch syndrome.
    van Liere ELSA; de Boer NKH; Dekker E; van Leerdam ME; de Meij TGJ; Ramsoekh D
    Aliment Pharmacol Ther; 2022 Apr; 55(7):778-788. PubMed ID: 35181895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary volatile organic compounds and faecal microbiome profiles in colorectal cancer.
    McFarlane M; Millard A; Hall H; Savage R; Constantinidou C; Arasaradnam R; Nwokolo C
    Colorectal Dis; 2019 Nov; 21(11):1259-1269. PubMed ID: 31282600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exhaled VOC detection in lung cancer screening: a comprehensive meta-analysis.
    Fan X; Zhong R; Liang H; Zhong Q; Huang H; He J; Chen Y; Wang Z; Xie S; Jiang Y; Lin Y; Chen S; Liang W; He J
    BMC Cancer; 2024 Jun; 24(1):775. PubMed ID: 38937687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of colorectal cancer (CRC) by urinary volatile organic compound analysis.
    Arasaradnam RP; McFarlane MJ; Ryan-Fisher C; Westenbrink E; Hodges P; Thomas MG; Chambers S; O'Connell N; Bailey C; Harmston C; Nwokolo CU; Bardhan KD; Covington JA
    PLoS One; 2014; 9(9):e108750. PubMed ID: 25268885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Volatile organic compounds as new biomarkers for colorectal cancer: a review.
    Di Lena M; Porcelli F; Altomare DF
    Colorectal Dis; 2016 Jul; 18(7):654-63. PubMed ID: 26752703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Curative Colorectal Cancer Surgery on Exhaled Volatile Organic Compounds and Potential Implications in Clinical Follow-up.
    Altomare DF; Di Lena M; Porcelli F; Travaglio E; Longobardi F; Tutino M; Depalma N; Tedesco G; Sardaro A; Memeo R; de Gennaro G
    Ann Surg; 2015 Nov; 262(5):862-6; discussion 866-7. PubMed ID: 26583677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of faecal
    Wong SH; Kwong TNY; Chow TC; Luk AKC; Dai RZW; Nakatsu G; Lam TYT; Zhang L; Wu JCY; Chan FKL; Ng SSM; Wong MCS; Ng SC; Wu WKK; Yu J; Sung JJY
    Gut; 2017 Aug; 66(8):1441-1448. PubMed ID: 27797940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Stool-Based Protein Biomarkers for Improved Colorectal Cancer Screening: A Case-Control Study.
    Bosch LJW; de Wit M; Pham TV; Coupé VMH; Hiemstra AC; Piersma SR; Oudgenoeg G; Scheffer GL; Mongera S; Sive Droste JT; Oort FA; van Turenhout ST; Larbi IB; Louwagie J; van Criekinge W; van der Hulst RWM; Mulder CJJ; Carvalho B; Fijneman RJA; Jimenez CR; Meijer GA
    Ann Intern Med; 2017 Dec; 167(12):855-866. PubMed ID: 29159365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.